Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Evolocumab on Coronary Endothelial Function

NCT03500302 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT03500302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03500302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Evolocumab on Coronary Endothelial Function
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
May 4, 2018
Completion date
November 30, 2019
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, human immunodeficiency virus